These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12734680)

  • 21. Dexrazoxane abrogates acute doxorubicin toxicity in marmoset ovary.
    Salih SM; Ringelstetter AK; Elsarrag MZ; Abbott DH; Roti EC
    Biol Reprod; 2015 Mar; 92(3):73. PubMed ID: 25609833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice.
    Mizuno Y; Naoi T; Nishikawa M; Rattanakiat S; Hamaguchi N; Hashida M; Takakura Y
    J Control Release; 2010 Jan; 141(2):252-9. PubMed ID: 19778560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia.
    Pelz JO; Vetterlein M; Grimmig T; Kerscher AG; Moll E; Lazariotou M; Matthes N; Faber M; Germer CT; Waaga-Gasser AM; Gasser M
    Ann Surg Oncol; 2013 Apr; 20(4):1105-13. PubMed ID: 23456378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.
    Loi M; Marchiò S; Becherini P; Di Paolo D; Soster M; Curnis F; Brignole C; Pagnan G; Perri P; Caffa I; Longhi R; Nico B; Bussolino F; Gambini C; Ribatti D; Cilli M; Arap W; Pasqualini R; Allen TM; Corti A; Ponzoni M; Pastorino F
    J Control Release; 2010 Jul; 145(1):66-73. PubMed ID: 20346382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative plasma and tissue distribution of Sun Pharma's generic doxorubicin HCl liposome injection versus Caelyx
    Burade V; Bhowmick S; Maiti K; Zalawadia R; Jain D; Rajamannar T
    Cancer Chemother Pharmacol; 2017 May; 79(5):899-913. PubMed ID: 28349166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer.
    Charrois GJ; Allen TM
    Biochim Biophys Acta; 2004 May; 1663(1-2):167-77. PubMed ID: 15157619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum uptake of doxorubicin intravesically administered soon after transurethral resection of bladder carcinoma].
    Nagakura K; Takao M; Odajima K; Ieda K; Fujioka T; Hayakawa M; Murai M; Nakamura H
    Hinyokika Kiyo; 1989 Sep; 35(9):1509-12. PubMed ID: 2816617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An anti-doxorubicin monoclonal antibody modulates kinetic and dynamic characteristics of the drug.
    Sardini A; Villa E; Morelli D; Ghione M; Ménard S; Colnaghi MI; Balsari A
    Int J Cancer; 1992 Feb; 50(4):617-20. PubMed ID: 1537626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermal sensitization using induced oxidative stress decreases tumor growth in an in vivo model of hyperthermic intraperitoneal perfusion.
    Razavi R; Harrison LE
    Ann Surg Oncol; 2010 Jan; 17(1):304-11. PubMed ID: 19711132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft.
    Luo FR; Yang Z; Dong H; Camuso A; McGlinchey K; Fager K; Flefleh C; Kan D; Inigo I; Castaneda S; Rose WC; Kramer RA; Wild R; Lee FY
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):455-64. PubMed ID: 15947929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapy.
    Chang CH; Stabin MG; Chang YJ; Chen LC; Chen MH; Chang TJ; Lee TW; Ting G
    Cancer Biother Radiopharm; 2008 Dec; 23(6):749-58. PubMed ID: 19111045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW; Allen TM
    J Control Release; 2008 Feb; 126(1):50-8. PubMed ID: 18068849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics of cyclophosphamide, adriamycin and adriamycin prodrug (HMR 1928) using an ex vivo isolated perfused human lung model (IHLP)].
    Mürdter TE; Linder A; Friedel G; McClellan M; Bohnenstengel F; Sperker B; Kroemer HK; Toomes H; Freitag L; Fritz P
    Pneumologie; 2000 Nov; 54(11):494-8. PubMed ID: 11132546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The protective effect of heat shock protein 72 by Doxorubicin in cold ischemia-reperfusion injury of the rat liver].
    Chen H; Peng CH; Deng XX; Qiu WH; Shen BY; Yang WP; Li HW
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):310-3. PubMed ID: 16635388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.
    Huang SK; Stauffer PR; Hong K; Guo JW; Phillips TL; Huang A; Papahadjopoulos D
    Cancer Res; 1994 Apr; 54(8):2186-91. PubMed ID: 8174126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy.
    Luo Y; Chihara Y; Fujimoto K; Sasahira T; Kuwada M; Fujiwara R; Fujii K; Ohmori H; Kuniyasu H
    Eur J Cancer; 2013 Feb; 49(3):741-51. PubMed ID: 23040637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of pegylated liposomal doxorubicin administered by intraoperative hyperthermic intraperitoneal chemotherapy to patients with advanced ovarian cancer and peritoneal carcinomatosis.
    Salvatorelli E; De Tursi M; Menna P; Carella C; Massari R; Colasante A; Iacobelli S; Minotti G
    Drug Metab Dispos; 2012 Dec; 40(12):2365-73. PubMed ID: 22972909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
    Pastorino F; Brignole C; Di Paolo D; Nico B; Pezzolo A; Marimpietri D; Pagnan G; Piccardi F; Cilli M; Longhi R; Ribatti D; Corti A; Allen TM; Ponzoni M
    Cancer Res; 2006 Oct; 66(20):10073-82. PubMed ID: 17047071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
    Pastorino F; Brignole C; Marimpietri D; Cilli M; Gambini C; Ribatti D; Longhi R; Allen TM; Corti A; Ponzoni M
    Cancer Res; 2003 Nov; 63(21):7400-9. PubMed ID: 14612539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.
    Arnold RD; Slack JE; Straubinger RM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 808(2):141-52. PubMed ID: 15261807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.